Novartis AG · Basel Switzerland ·(NYSE: NVS)(Swiss: NOVN)
Company Description
Phone: +41-61-324-1111
Fax: +41-61-324-8001
Rankings
- Swiss Market
- Dow Jones STOXX 50
- Dow Jones Global Titans
- #26 in FT Global 500
View Novartis AG Locations On A US Map
This link will open in a new window
Although it's based in neutral Switzerland, Novartis has been aggressive in attacking illnesses on four fronts: pharmaceuticals, vaccines and diagnostics, generics, and consumer health. Its largest division, Pharmaceuticals, develops and manufactures prescription drugs to treat a wide spectrum of ailments. Vaccine and Diagnostics manufactures vaccines and blood-screening tools. Its Sandoz generics subsidiary produces generic drugs, as well as active pharmaceutical ingredients. Novartis' consumer health unit includes OTC medications such as Benefiber, Excedrin, and Theraflu, along with CIBA Vision's contact lenses and eye care products and Animal Health's companion and agricultural animal care products. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Novartis AG Executives
31 executives listed for Novartis AG's Basel, location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Daniel Vasella | Network |
| Vice Chairman | Ulrich Lehner | Network |
| Vice Chairman | Hans-Jörg Rudloff | Network |
Competition
Competitive Landscape for Novartis AG
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Novartis AG Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
